Alzamend Neuro's AL001 formulation highlights its potential to treat disorders such a Alzheimer's
By potentially removing the requirement for lithium therapeutic drug monitoring (TDM), AL001 could transform treatment for at-risk patient groups and enhance clinical outcomes
























